Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Stieler, Kristin ^a   Fischer, Nicole ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOBEC3 PROTEIN, HUMAN; APOBEC3 PROTEIN, MOUSE; APOBEC3B PROTEIN, HUMAN; APOBEC3C PROTEIN, HUMAN; APOBEC3F PROTEIN, HUMAN; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; MESSENGER RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL; CONCENTRATION PROCESS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; GAMMARETROVIRUS INFECTION; HUMAN; HUMAN CELL; INFECTION PREVENTION; INFECTION SENSITIVITY; MALE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; VIRION; VIRUS INFECTIVITY; VIRUS RESISTANCE; ANIMAL; CELL LINE; GENE VECTOR; GENETICS; IMMUNOBLOTTING; METABOLISM; MOUSE; POLYMERASE CHAIN REACTION; RETROVIRUS; TUMOR CELL CULTURE;

GAMMARETROVIRUS;

ANIMALS; CELL LINE; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; GAMMARETROVIRUS; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; MICE; POLYMERASE CHAIN REACTION; RETROVIRIDAE; RNA, MESSENGER; TUMOR CELLS, CULTURED; VIRION;

EID: 77955398967     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011738     Document Type: Article

References (49)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
2. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR (2009) XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 106: 16351-16356.
3. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
4. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, et al. (2008) Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 43: 277-283.
5. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, et al. (2009) Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6: 92.
6. Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, et al. (2009) Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 83: 6995-7003.
7. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5: e8519.
8. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S H, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
9. van Kuppeveld FJ, Jong AS, Lanke KH, Verhaegh GW, Melchers WJ, et al. (2010) Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. Bmj 340: c1018.
10. Stieler K.S.C., Lavanya M, Aepfelbacher M, Stocking C, Fischer N (2010) Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology.
11. Groom HC, Yap MW, Galao RP, Neil SJ, Bishop KN (2010) Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A.
12. Rodriguez JJ, Goff SP (2009) Xenotropic Murine Leukemia Virus-Related Virus Establishes an Efficient Spreading Infection and Exhibits Enhanced Transcrip-tional Activity In Prostate Carcinoma Cells. J Virol.
13. Holmes RK, Malim MH, Bishop KN (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32: 118-128.
14. Chiu YL, Greene WC (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retro-elements. Annu Rev Immunol 26: 317-353.
15. Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR (2006) APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 34: 89-95.
16. Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS, et al. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A 103: 8780-8785.
17. Chen H, Lilley CE, Yu Q, Lee DV, Chou J, et al. (2006) APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 16: 480-485.
18. Dutko JA, Schafer A, Kenny AE, Cullen BR, Curcio MJ (2005) Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol 15: 661-666.
19. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, et al. (2005) APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433: 430-433.
20. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Lower J, et al. (2006) APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 281: 22161-22172.
21. Turelli P, Mangeat B, Jost S, Vianin S, Trono D (2004) Inhibition of hepatitis B virus replication by APOBEC3G. Science 303: 1829.
22. Turelli P, Trono D (2005) Editing at the crossroad of innate and adaptive immunity. Science 307: 1061-1065.
23. Zhang L, Li X, Ma J, Yu L, Jiang J, et al. (2008) The incorporation of APOBEC3 proteins into murine leukemia viruses. Virology 378: 69-78.
24. Doehle BP, Bogerd HP, Wiegand HL, Jouvenet N, Bieniasz PD, et al. (2006) The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles. J Virol 80: 12102-12108.
25. Okeoma CM, Lovsin N, Peterlin BM, Ross SR (2007) APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445: 927-930.
26. Takeda E, Tsuji-Kawahara S, Sakamoto M, Langlois MA, Neuberger MS, et al. (2008) Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. J Virol 82: 10998-11008.
27. Browne EP, Littman DR (2008) Species-specific restriction of apobec3-mediated hypermutation. J Virol 82: 1305-1313.
28. Low A, Okeoma CM, Lovsin N, de las Heras M, Taylor TH, et al. (2009) Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 385: 455-463.
29. Rulli SJ, Jr., Mirro J, Hill SA, Lloyd P, Gorelick RJ, et al. (2008) Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J Virol 82: 6566-6575.
30. Goff SP (2007) Host factors exploited by retroviruses. Nat Rev Microbiol 5: 253-263.
31. Jern P, Coffin JM (2008) Host-retrovirus arms race: trimming the budget. Cell Host Microbe 4: 196-197.
32. Stopak K, de Noronha C, Yonemoto W, Greene WC (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12: 591-601.
33. Derse D, Hill SA, Princler G, Lloyd P, Heidecker G (2007) Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc Natl Acad Sci U S A 104: 2915-2920.
34. Chiu YL, Greene WC (2006) APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle. J Biol Chem 281: 8309-8312.
35. Doehle BP, Schafer A, Wiegand HL, Bogerd HP, Cullen BR (2005) Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J Virol 79: 8201-8207.
36. Bishop KN, Holmes RK, Malim MH (2006) Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol 80: 8450-8458.
37. Kobayashi M, Takaori-Kondo A, Shindo K, Abudu A, Fukunaga K, et al. (2004) APOBEC3G targets specific virus species. J Virol 78: 8238-8244.
38. Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, et al. (2006) Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr Biol 16: 1565-1570.
39. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry, et al. (2010) Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol 84: 5719-5729.
40. Beyer WR, Westphal M, Ostertag W, von Laer D (2002) Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glyco-protein: generation, concentration, and broad host range. J Virol 76: 1488-1495.
41. Schwieger M, Lohler J, Friel J, Scheller M, Horak I, et al. (2002) AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med 196: 1227-1240.
42. Laker C, Stocking C, Bergholz U, Hess N, De Lamarter JF, et al. (1987) Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sci U S A 84: 8458-8462.
43. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, et al. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78: 6073-6076.
44. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31.
45. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, et al. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res.
46. Yu Q, Chen D, Konig R, Mariani R, Unutmaz D, et al. (2004) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol Chem 279: 53379-53386.
47. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, et al. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol 14: 1392-1396.
48. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, et al. (2007) An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 104: 1655-1660.
49. Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM, et al. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83: 9474-9485.